Lyrica is classified as which schedule of controlled substance?

Lyrica, the brand name for pregabalin, is classified as a Schedule V controlled substance under the Controlled Substances Act. Schedule V substances are those that have a low potential for abuse relative to the substances in the higher schedules (I through IV), have accepted medical uses, and have limited physical or psychological dependence potential.

Pregabalin is used primarily to treat nerve pain, fibromyalgia, and seizures, demonstrating its legitimate medical applications. While it can cause some level of dependence or abuse, it is considered to have a lower risk compared to Schedule IV substances like benzodiazepines, and significantly lower than those in Schedule II or I, such as opioids and heroin, respectively.

Understanding the classification of drugs, including Lyrica, is vital for pharmacists and pharmacy technicians as it directly affects prescribing practices, dispensing regulations, and the understanding of a drug's potential for abuse or dependence.